Richmond Pharmacology enhances its established GE MUSE platform with the State-of-the-art Mortara 12-lead telemetry setup

Posted:
8
November 2011

Richmond Pharmacology enhances its established GE MUSE platform with theState-of-the-art Mortara 12-lead telemetry setupEnhancing our well tested GE MUSE platform, Richmond Pharmacology today added the state-of-the-art Mortara 12-lead telemetry setup providing the most comprehensive TQT measurement platform available.Key features include:

  • 12-lead Telemetry Monitoring

With the Mortara X12+  and T12S  transmitters, the Surveyor  Telemetry Central System enables continuous 12-lead monitoring and trending for thorough evaluation of ECG intervals, ST segment change, and arrhythmias using VERITAS  ECG algorithms.

  • 12-lead ECG On-Demand

Continuous 12-lead monitoring enables diagnostic 12-lead ECG acquisition on-demand without any additional device or patient hookup.  12-lead ECGs with VERITAS measurements and interpretation can be printed and exported to an E-Scribe� data management system either manually or automatically.This is an alternative to our established GE GETEMED 12-lead Holter platform.At Richmond Pharmacology we are so confident that we can deliver a successful TQT study we ensure a fixed price guarantee. Furthermore our confidence in our experience means that should we fail to show Thorough QT assay sensitivity we will repeat your study at no cost to you.Contact a member of our Business Development team now to discuss your prospective QT study requirements.

Latest news

Upcoming Event

EUFEMED, 3rd Annual Conference, 28-30 April 2021

28-30 April 2021
Dr Jorg Taubel will co-chair a session on day one, which explores how technology has reduced the risks of pandemic effects on Phase I and II trial performance.
View event

Making gains in drug development

September 2, 2021
Keith Berelowitz outlines the innovations in the design and delivery of clinical trials
Read more

Inclisirin hailed as a 'gamechanger' gains approval for NHS patients

September 2, 2021
This novel therapeutic drug has potential to impact millions at risk of heart attack and stroke.
Read more

Richmond Pharmacology listed in the Alantra Pharma Fast 50

July 13, 2021
Richmond has been included in a top 50 list of the UK’s fastest-growing, privately-owned pharmaceutical businesses. 
Read more